AG˹ٷ

STOCK TITAN

[Form 4] CryoPort, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

On 08/04/2025 Cryoport (CYRX) filed a Form 4 showing that President & CEO Jerrell Shelton exercised 25,000 stock options at an exercise price of $5 on 07/31/2025. This was a cash exercise with no subsequent sale of the underlying shares. As a result, Shelton’s direct holdings rose to 1,037,419 common shares.

The option was originally granted on 08/20/2015 and vested in equal monthly installments over 48 months; the filing confirms the award is now fully exercised and retired. The transaction modestly increases insider ownership and may indicate management confidence, but represents only about 2.4 % of Shelton’s total stake and does not involve open-market buying. No additional financial metrics, earnings data, or strategic commentary were included in the filing.

Il 04/08/2025 Cryoport (CYRX) ha presentato un Modulo 4 che mostra come il Presidente e CEO Jerrell Shelton abbia esercitato 25.000 opzioni azionarie al prezzo di esercizio di 5 dollari il 31/07/2025. Si è trattato di un esercizio in contanti senza successiva vendita delle azioni sottostanti. Di conseguenza, la partecipazione diretta di Shelton è salita a 1.037.419 azioni ordinarie.

L'opzione era stata originariamente concessa il 20/08/2015 e maturava in rate mensili uguali per 48 mesi; la documentazione conferma che il premio è ora completamente esercitato e annullato. La transazione aumenta modestamente la proprietà degli insider e può indicare fiducia da parte del management, ma rappresenta solo circa il 2,4% della quota totale di Shelton e non implica acquisti sul mercato aperto. Nel modulo non sono stati inclusi ulteriori dati finanziari, risultati economici o commenti strategici.

El 04/08/2025 Cryoport (CYRX) presentó un Formulario 4 que muestra que el Presidente y CEO Jerrell Shelton ó 25.000 opciones sobre acciones a un precio de ejercicio de 5 dólares el 31/07/2025. Se trató de un ejercicio en efectivo sin venta posterior de las acciones subyacentes. Como resultado, las participaciones directas de Shelton aumentaron a 1.037.419 acciones comunes.

La opción fue otorgada originalmente el 20/08/2015 y se consolidó en cuotas mensuales iguales durante 48 meses; la presentación confirma que el premio ahora está completamente ejercido y cancelado. La transacción incrementa modestamente la propiedad de los insiders y puede indicar confianza en la gestión, pero representa solo alrededor del 2,4% de la participación total de Shelton y no implica compras en el mercado abierto. No se incluyeron métricas financieras adicionales, datos de ganancias ni comentarios estratégicos en la presentación.

2025� 8� 4�, Cryoport(CYRX)� Jerrell Shelton 사장 � CEO가 2025� 7� 31일에 행사가� 5달러� 25,000� 스톡옵션� 행사했다� 내용� 담은 Form 4� 제출했습니다. 이는 현금 행사였으며, 기초 주식� 추가 매도� 없었습니�. � 결과 Shelton� 직접 보유 주식 수는 1,037,419� 보통�� 증가했습니다.

해당 옵션은 2015� 8� 20일에 처음 부여되었으�, 48개월� 걸쳐 매월 동일� 비율� 권리가 발생했습니다. 제출� 문서� 따르� 해당 보상은 이제 완전� 행사되어 소멸되었습니�. 이번 거래� 내부� 지분을 소폭 늘리� 경영진의 신뢰� 나타� � 있으�, Shelton 전체 지분의 � 2.4%� 불과하며 공개 시장에서� 매수� 포함되지 않았습니�. 추가적인 재무 지�, 수익 데이� 또는 전략� 코멘트는 제출서류� 포함되지 않았습니�.

Le 04/08/2025, Cryoport (CYRX) a déposé un formulaire 4 indiquant que le Président et CEO Jerrell Shelton a exercé 25 000 options d'achat d'actions au prix d'exercice de 5 $ le 31/07/2025. Il s'agissait d'un exercice en numéraire sans vente ultérieure des actions sous-jacentes. En conséquence, les détentions directes de Shelton sont passées à 1 037 419 actions ordinaires.

L'option avait été initialement attribuée le 20/08/2015 et acquise par tranches mensuelles égales sur 48 mois ; le dépôt confirme que la récompense est désormais entièrement exercée et annulée. La transaction augmente modestement la participation des initiés et peut indiquer la confiance de la direction, mais ne représente qu'environ 2,4 % de la participation totale de Shelton et n'implique pas d'achat sur le marché ouvert. Aucun autre indicateur financier, donnée sur les bénéfices ou commentaire stratégique n'a été inclus dans le dépôt.

Am 04.08.2025 meldete Cryoport (CYRX) in einem Formular 4, dass Präsident und CEO Jerrell Shelton am 31.07.2025 25.000 Aktienoptionen zum Ausübungspreis von 5 USD ausgeübt hat. Dies war eine Barausübung ohne anschließenden Verkauf der zugrunde liegenden Aktien. Infolgedessen stieg Sheltons Direktbestand auf 1.037.419 Stammaktien.

Die Option wurde ursprünglich am 20.08.2015 gewährt und in gleichen monatlichen Raten über 48 Monate erworben; die Einreichung bestätigt, dass die Prämie nun vollständig ausgeübt und zurückgezogen wurde. Die Transaktion erhöht den Insiderbesitz moderat und kann auf Vertrauen des Managements hinweisen, macht jedoch nur etwa 2,4 % von Sheltons Gesamtanteil aus und beinhaltet keinen Kauf am offenen Markt. Weitere finanzielle Kennzahlen, Gewinnzahlen oder strategische Kommentare wurden in der Einreichung nicht angegeben.

Positive
  • CEO increased direct ownership by 25,000 shares, signalling continued commitment to the company.
  • No shares were sold, eliminating near-term selling pressure and suggesting confidence in future performance.
Negative
  • The transaction is small, adding only ~2.4 % to the CEO’s existing stake, limiting its signaling power.
  • Shares were acquired via option exercise rather than open-market purchase, providing a weaker valuation signal.

Insights

TL;DR � CEO adds 25k shares via option exercise; no sale, modestly positive signal but limited market impact.

The cash exercise at $5 eliminates 25,000 fully-vested options and lifts Shelton’s direct stake to roughly 1.04 million shares. Lack of selling removes immediate supply pressure and can be interpreted as incremental confidence, yet the size is immaterial relative to his existing position and Cryoport’s 49 million basic shares outstanding. Because the shares were not bought on the open market, the purchase does not necessarily reflect valuation views. Overall impact on share price or valuation is expected to be neutral to mildly positive.

Il 04/08/2025 Cryoport (CYRX) ha presentato un Modulo 4 che mostra come il Presidente e CEO Jerrell Shelton abbia esercitato 25.000 opzioni azionarie al prezzo di esercizio di 5 dollari il 31/07/2025. Si è trattato di un esercizio in contanti senza successiva vendita delle azioni sottostanti. Di conseguenza, la partecipazione diretta di Shelton è salita a 1.037.419 azioni ordinarie.

L'opzione era stata originariamente concessa il 20/08/2015 e maturava in rate mensili uguali per 48 mesi; la documentazione conferma che il premio è ora completamente esercitato e annullato. La transazione aumenta modestamente la proprietà degli insider e può indicare fiducia da parte del management, ma rappresenta solo circa il 2,4% della quota totale di Shelton e non implica acquisti sul mercato aperto. Nel modulo non sono stati inclusi ulteriori dati finanziari, risultati economici o commenti strategici.

El 04/08/2025 Cryoport (CYRX) presentó un Formulario 4 que muestra que el Presidente y CEO Jerrell Shelton ó 25.000 opciones sobre acciones a un precio de ejercicio de 5 dólares el 31/07/2025. Se trató de un ejercicio en efectivo sin venta posterior de las acciones subyacentes. Como resultado, las participaciones directas de Shelton aumentaron a 1.037.419 acciones comunes.

La opción fue otorgada originalmente el 20/08/2015 y se consolidó en cuotas mensuales iguales durante 48 meses; la presentación confirma que el premio ahora está completamente ejercido y cancelado. La transacción incrementa modestamente la propiedad de los insiders y puede indicar confianza en la gestión, pero representa solo alrededor del 2,4% de la participación total de Shelton y no implica compras en el mercado abierto. No se incluyeron métricas financieras adicionales, datos de ganancias ni comentarios estratégicos en la presentación.

2025� 8� 4�, Cryoport(CYRX)� Jerrell Shelton 사장 � CEO가 2025� 7� 31일에 행사가� 5달러� 25,000� 스톡옵션� 행사했다� 내용� 담은 Form 4� 제출했습니다. 이는 현금 행사였으며, 기초 주식� 추가 매도� 없었습니�. � 결과 Shelton� 직접 보유 주식 수는 1,037,419� 보통�� 증가했습니다.

해당 옵션은 2015� 8� 20일에 처음 부여되었으�, 48개월� 걸쳐 매월 동일� 비율� 권리가 발생했습니다. 제출� 문서� 따르� 해당 보상은 이제 완전� 행사되어 소멸되었습니�. 이번 거래� 내부� 지분을 소폭 늘리� 경영진의 신뢰� 나타� � 있으�, Shelton 전체 지분의 � 2.4%� 불과하며 공개 시장에서� 매수� 포함되지 않았습니�. 추가적인 재무 지�, 수익 데이� 또는 전략� 코멘트는 제출서류� 포함되지 않았습니�.

Le 04/08/2025, Cryoport (CYRX) a déposé un formulaire 4 indiquant que le Président et CEO Jerrell Shelton a exercé 25 000 options d'achat d'actions au prix d'exercice de 5 $ le 31/07/2025. Il s'agissait d'un exercice en numéraire sans vente ultérieure des actions sous-jacentes. En conséquence, les détentions directes de Shelton sont passées à 1 037 419 actions ordinaires.

L'option avait été initialement attribuée le 20/08/2015 et acquise par tranches mensuelles égales sur 48 mois ; le dépôt confirme que la récompense est désormais entièrement exercée et annulée. La transaction augmente modestement la participation des initiés et peut indiquer la confiance de la direction, mais ne représente qu'environ 2,4 % de la participation totale de Shelton et n'implique pas d'achat sur le marché ouvert. Aucun autre indicateur financier, donnée sur les bénéfices ou commentaire stratégique n'a été inclus dans le dépôt.

Am 04.08.2025 meldete Cryoport (CYRX) in einem Formular 4, dass Präsident und CEO Jerrell Shelton am 31.07.2025 25.000 Aktienoptionen zum Ausübungspreis von 5 USD ausgeübt hat. Dies war eine Barausübung ohne anschließenden Verkauf der zugrunde liegenden Aktien. Infolgedessen stieg Sheltons Direktbestand auf 1.037.419 Stammaktien.

Die Option wurde ursprünglich am 20.08.2015 gewährt und in gleichen monatlichen Raten über 48 Monate erworben; die Einreichung bestätigt, dass die Prämie nun vollständig ausgeübt und zurückgezogen wurde. Die Transaktion erhöht den Insiderbesitz moderat und kann auf Vertrauen des Managements hinweisen, macht jedoch nur etwa 2,4 % von Sheltons Gesamtanteil aus und beinhaltet keinen Kauf am offenen Markt. Weitere finanzielle Kennzahlen, Gewinnzahlen oder strategische Kommentare wurden in der Einreichung nicht angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SHELTON JERRELL

(Last) (First) (Middle)
C/O CRYOPORT INC.
112 WESTWOOD PLACE, SUITE 350

(Street)
BRENTWOOD TN 37027

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President, CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/31/2025 M 25,000(1) A $5 1,037,419 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $5 07/31/2025 M 25,000(1) (2) 08/20/2025 Common Stock 25,000 $0.00 25,000 D
Explanation of Responses:
1. This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
2. 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015.
/s/ Jerrell Shelton 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CYRX shares did CEO Jerrell Shelton acquire in this Form 4?

He acquired 25,000 common shares through option exercise.

What was the exercise price of the options?

The options were exercised at $5.00 per share.

What is Shelton’s total direct ownership after the transaction?

His direct holdings stand at 1,037,419 CYRX shares.

Were any shares sold in connection with the option exercise?

No; the filing states there was no sale of the underlying shares.

When were the options originally granted and how did they vest?

Granted on 08/20/2015, vesting 1�48 monthly beginning 08/19/2015 over 48 months.

Does the Form 4 include any earnings or guidance information?

No. The filing only details insider transactions and includes no financial performance data.
Cryoport Inc

NASDAQ:CYRX

CYRX Rankings

CYRX Latest News

CYRX Latest SEC Filings

CYRX Stock Data

337.92M
47.60M
3.67%
98.79%
5.38%
Integrated Freight & Logistics
Pharmaceutical Preparations
United States
BRENTWOOD